Focus Stocks

Facebook (FB)

Facebook (FB)


JP Morgan (JPM)

JP Morgan (JPM)


AutoZone (AZO)

AutoZone (AZO)


Yahoo (YHOO)

Yahoo (YHOO)


Apple (AAPL)

Apple (AAPL)


Featured Stories

Medtronic Reports Fourth Quarter Earnings

Medtronic Reports Fourth Quarter Earnings


Cracker Barrel Reports Earnings, Increases Guidance

Cracker Barrel Reports Earnings, Increases Guidance


Best ETFs For Facebook Exposure

Best ETFs For Facebook Exposure


Is Yum! Brands Closing in to Support?

Is Yum! Brands Closing in to Support?


Intuitive Surgical Bullish Signs

Intuitive Surgical Bullish Signs


Cepheid Schedules 2011 Fourth Quarter and Full Year Financial Results Announcement and Webcast


SUNNYVALE, Calif., Jan. 11, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2011 fourth quarter and full year ended December 31, 2011, on Thursday, January 26, 2012, after the close of the market.

The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, January 26, 2012, to discuss the results.  To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants and investors may also listen to the live teleconference call by dialing (866) 713-8395 or (617) 597-5309, and entering participant code 42214013.  A replay will be available for seven days beginning at 4 p.m. Pacific Time.  Access numbers for this replay are (888) 286-8010 or (617) 801-6888, with passcode 57636855.

About Cepheid

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.  Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

CONTACTS:

 

For Media Inquiries:

For Investor Inquiries:

 

 

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400 8377

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

 

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400 8329

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

 

 

SOURCE Cepheid



Real Money Pro from TheStreet: Headlined by legendary hedge fund manager Doug Kass, our team of market technicians and professional traders hand you unique perspectives and breakthrough investment opportunities. Access this exciting service -- Real Money Pro -- FREE, right now!

TradersHuddle Search

Sponsored By:

Stock Search:


Site Search:

Loading

Stock Market

Loading
Chart
o Dow Jones 12,370.89 ▼131.92 (-1.06%)
o S&P 500 1,304.24 ▼12.39 (-0.94%)
o NASDAQ 2,815.63 ▼23.45 (-0.83%)
INDEXDJX:.DJI

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:12,370.89 Trade time:2:13PM EDT Value change:▼131.92 (-1.06%)
INDEXSP:.INX

S&P 500

Company ID [INDEXSP:.INX] Last trade:1,304.24 Trade time:2:13PM EDT Value change:▼12.39 (-0.94%)
INDEXNASDAQ:.IXIC

NASDAQ

Company ID [INDEXNASDAQ:.IXIC] Last trade:2,815.63 Trade time:2:13PM EDT Value change:▼23.45 (-0.83%)
Copyright © 2011 TradersHuddle.com. All Rights Reserved.